Company CVAbout Mercury Laboratories Ltd 
Mercury Laboratories Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, the Company converted into Private Limited Company & incorporated in February, 1982. Later, it further converted into Limited Company in 1992 in Maharashtra. The Company is engaged in the business of Pharmaceutical items, medicinal drugs and formulations. It is a profit making and dividend paying public limited company.
Company Coordinates
Company Details
1st Floor 18 Shreeji Bhuwan 51, Princess Street Mangaladas Rd Mumbai Maharashtra : 400002
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 1.20 Cr
Number of Shares
12 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
31-Mar-2015
12
1.20
400
10
Unspecified
31-Mar-2015
12
1.20
400
10
Unspecified
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Shah Dilip Ramanlal Huf (25.88%)
Highest Public shareholder
Rajeshri Ketan Shah (2.2%)
Individual Investors Holdings
16.71%
Board of Directors
Management
Designation
Remuneration
Rajendra R Shah
ED / MD / Promoter
18.86 lacs
Dilip R Shah
Non Executive Director
29.0 k
Divyakant Ramniklal Zaveri
Chairman & Independent Directo
44.0 k
Bharat Dhirajlal Mehta
Independent Non Exe. Director
44.0 k
Paresh Mistry
Non-Exec & Non-Independent Dir
35.0 k
Janki Shah
Non Executive Director
24.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Others
37.53
71.62%
Paracetamol Tab
4.85
9.26%
Gravidol Tablet
3.94
7.52%
Others
Others
Paracetamol Tab
Paracetamol Tab
Gravidol Tablet
Gravidol Tablet
Stock DNARevenue and Profits:
Net Sales:
19 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
Pharmaceuticals & Biotechnology
INR 105 Cr (Micro Cap)
21.00
34
0.41%
0.06
8.81%
1.82
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
